Efficient photocatalytic degradation of metoprolol using activated carbon supported NiFe-layered double hydroxides (NiFe-LDH/C) under solar-driven simulation

The efficient photocatalytic degradation of pharmaceuticals in wastewater is critically important for environmental protection. The synthesis and characterization of NiFe-LDH/C for the photocatalytic degradation of selected β-blockers, specifically metoprolol, under UV light conditions were investigated in this study. The study aimed to explore the potential of NiFe-LDH/C as a catalyst for the degradation of metoprolol, a commonly used pharmaceutical compound in the treatment of chronic diseases such as high blood pressure and chest pains, which is frequently detected in wastewater. The selection of NiFe-LDH/C was driven by the need for materials with high photocatalytic activity, the ability to generate reactive oxygen species and enhance charge separation, and stability under solar light. Activated carbon was employed as a support to increase the surface area and improve the dispersion of the LDH particles, thereby enhancing overall photocatalytic efficiency. The results showed that NiFe-LDH/C exhibited excellent photocatalytic activity in degrading metoprolol under both UV and sunlight-mediated conditions, with degradation efficiencies of over 89%. Furthermore, the characterization of the NiFe-LDH/C catalyst revealed its stability and recyclability, making it a promising candidate for the efficient removal of pharmaceutical compounds from wastewater through photocatalytic degradation. The characterization results showed that the NiFe-LDH/C exhibited a high degree of crystallinity and a well-defined layered structure. The photocatalytic experiments demonstrated that the NiFe-LDH/C was effective in degrading metoprolol and ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) was used to elucidate the degradation products of metoprolol in water.